Document Detail

Prevalence of antiphospholipid antibodies in Syrian patients with thrombosis.
MedLine Citation:
PMID:  19801789     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Antiphospholipid antibodies (aPL) are a heterogeneous family of antibodies associated with thrombosis and other complications. OBJECTIVE: To study the prevalence of aPL in patients with thrombosis at Aleppo University Hospitals, Syria. METHODS: One hundred and fifty-seven patients with venous and arterial thrombosis and 63 healthy controls were studied. Anticardiolipin antibodies (aCL) and Lupus anticoagulant (LA) were determined. RESULTS: Thirty-four out of 157 (21.7%) patients with thrombosis had some type of aPL. aPL was also found in four healthy subjects (4/63=6.3%). Eighteen patients (11.5%) were positive for LA, 20 (12.7%) for aCL antibodies and 4 (2.6%) were positive for more than one aPL. Patients without risk factors for thrombosis and having positive aPL were 23/34 (67.7%). Fourteen out of 78 (17.9%) patients with arterial thrombosis, and 20/79 (25.3%) with venous thrombosis were positive for at least one aPL. CONCLUSION: Our study showed a significant prevalence of aPL in patients with thrombosis. It seems that aPL is a risk factor for venous and arterial thrombosis, especially in patients with no conventional risk factors.
Ali Deeb; Said Hamdoun; Khaled Dababo
Related Documents :
7136439 - The significance of patient's age and sex in the interpretation of signs and symptoms i...
18159459 - Predictors of a positive duplex scan in patients with a clinical presentation compatibl...
1445959 - Comparison of markers of coagulation activation in patients under oral anticoagulation ...
3614469 - Risk evaluation of thromboembolic diseases according to functional test data in patient...
11436069 - Lepirudin is a safe and effective anticoagulant for patients with heparin-associated an...
18458119 - Venous thromboembolic events and erythropoiesis-stimulating agents: an update.
25205209 - Impact of imiglucerase supply shortage on clinical and laboratory parameters in norrbot...
11936519 - Relationship between supramaximal flow during cough and mortality in motor neurone dise...
3348719 - Clonidine effect on spasticity: a clinical trial.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Iranian journal of immunology : IJI     Volume:  6     ISSN:  1735-1383     ISO Abbreviation:  Iran J Immunol     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-10-05     Completed Date:  2010-01-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101282932     Medline TA:  Iran J Immunol     Country:  Iran    
Other Details:
Languages:  eng     Pagination:  154-9     Citation Subset:  IM    
Departments of Internal Medicine, Aleppo University, Syria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antibodies, Anticardiolipin / blood*
Antibodies, Antiphospholipid / blood*
Lupus Coagulation Inhibitor / blood*
Middle Aged
Seroepidemiologic Studies
Syria / epidemiology
Thrombosis / blood*,  diagnosis,  epidemiology
Young Adult
Reg. No./Substance:
0/Antibodies, Anticardiolipin; 0/Antibodies, Antiphospholipid; 0/Lupus Coagulation Inhibitor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Serum Levels of TNF-alpha, TNF-alphaRI, TNF-alphaRII and IL-12 in Treated Rheumatoid Arthritis Patie...
Next Document:  Presidential Address: Quarantining Women: Venereal Disease Rapid Treatment Centers in World War II A...